Suchergebnisse - (Subject:"SARS-CoV-2")

PubPharm (2.156)

21

Manidipine is not a potential inhibitor against SARS-CoV-2 main protease

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Zhang, R. | Zhou, J. | Yan, H. | +3

22

Inter-hospital transfer and clinical outcomes for people with COVID-19 admitted to intensive care units in Australia

enthalten in: The Medical journal of Australia | 2024

von Maan, P. | Bansal, A. | Nayyar, V.

CommentOn: Med J Aust. 2023 Jun 5;218(10):474-481. - PMID 37037671

23

Speed up relief for long COVID through grassroots clinical trials

enthalten in: Nature | 2024

von Jamoulle, M. | Louazon, E. | Antonacci, T. | +1

24

Reevaluating severe acute respiratory syndrome coronavirus-2 donor testing policies : Balancing safety and efficiency in organ transplantation

enthalten in: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons | 2024

von Pouch, S. | La Hoz, R.

25

Sensitivity and specificity analysis of SARS-CoV-2 rapid antigen test

enthalten in: The American journal of emergency medicine | 2024

von Ito, H.

26

Spontaneous pneumomediastinum : A complication of SARS-CoV-2 variant delta infection in children

enthalten in: Pediatric pulmonology | 2024

von Prevost, B. | Leger, P. | Sileo, C. | +4

27

Reply : Infections and Stiff-Person Spectrum Disorders

enthalten in: Movement disorders clinical practice | 2024

von Giacomozzi, S. | Barone, V. | Merli, E. | +5

28

Stress and musculoskeletal pain in physiotherapists during the pandemic depend on a plethora of influencing factors

enthalten in: Chiropractic & manual therapies | 2024

von Finsterer, J. | Scorza, C. | Scorza, F. | +1

CommentOn: Chiropr Man Therap. 2023 Sep 12;31(1):34. - PMID 37700309

29

The SARS-CoV-2 spike protein induces lung cancer migration and invasion in a TLR2-dependent manner

enthalten in: Cancer communications (London, England) | 2024

von Kim, M. | Kim, J. | Shin, J. | +7

30

Novel small-molecule inhibitors of SARS-CoV-2 main protease with nanomolar antiviral potency

enthalten in: The Journal of infection | 2024

von Zhang, H. | Zhou, K. | Peng, F. | +15